BP000148-C047: Recombinant Mouse Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000148-CYT-148: Recombinant Mouse Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
Purity: > 98.0% as determined byGel filtration chromatography under non-denaturing conditions and reducing and non-reducing SDS-PAGE Silver Stained gel. <BP000148-CYT-173: Recombinant Rat Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The biological activity is measured by its ability to induce IL-10 secretion in COLO 205 (human colon carcinoma cells). The expected ED50 for this effect is 0.15-0.75 ug/ml.
Purity: > 97.0% as determined by RP-HPLC and SDS-PAGE.BP000148-CYT-328: Recombinant Human Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The Biological Activity was determined by the ability to activiate STAT following receptor ligand interaction.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000148-CYT-539: Recombinant Mouse Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The ED50 as determined by its ability to induce IL-10 secretion in Colo205 cells is less than 0.5 ng/ml, corresponding to a Specific Activity of 2 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000148-CYT-701: Recombinant Mouse Interleukin-22 (IL-22) Protein, Pegylated
Source: E. coli-derived.
The ED50 as determined by STAT3 phosphorylation assay in HepG cells. The activity in vitro was found to be ~ 10% compared to the non-pegylated mouse IL22.
Purity: > 98% by SDS-PAGE and RP-HPLC.